ÉúÎﻯѧϰÌâ½â´ð ÏÂÔØ±¾ÎÄ

£¨1£©ÔÚ°±»ù¼×õ£Á×ËáºÏ³Éø×÷ÓÃÏ£¬?°±¼°¶þÑõ»¯Ì¼Ê×ÏÈÔÚ¸Îϸ°ûÄںϳɰ±»ù¼×õ£Á×Ëᣬ·´Ó¦ÐèÏûºÄATP£» (2)ÔÚÄñ°±Ëá°±»ù¼×õ£×ªÒÆÃ¸´ß»¯Ï£¬ÔÚMg2+´æÔÚÏ£¬½«°±»ù¼×õ£»ù×ªÒÆ¸øÄñ°±ËáÉú³É¹Ï°±Ë᣻

(3)ÔÚ¾«°±»ùçúçêËáºÏ³Éø´ß»¯Ï£¬¹Ï°±ËáÓëÌ춬°±Ëá·´Ó¦Éú³É¾«°±»ùçúçêËᣬͬÑùÐèATP¹©ÄÜ£¬?¾«°±Ëá»ùçúçêËá¾­Áѽâø´ß»¯×ª±äΪ¾«°±Ëá¼°çúçêË᣻

(4)¾«°±ËáÔÚ¾«°±Ëáø×÷ÓÃÏÂË®½âÉú³ÉÄñ°±ËáºÍÄòËØ¡£?Äñ°±ËáÖØ¸´ÉÏÊö·´Ó¦£¬¹¹³ÉÄñ°±ËáÑ­»·¡£ °±¶Ô»úÌåÊÇÒ»Ö־綾ÎïÖÊ£¬Í¨¹ýÄñ°±ËáÑ­»·¿ÉÐγÉÒ»·Ö×ÓµÄÄòËØ¿ÉÇå³ýÁ½·Ö×ӵݱ»ùµª¼°Ò»·Ö×ÓµÄCO2£¬ÄòËØÊÇÖÐÐÔÎÞ¶¾ÎïÖÊ£¬Òò´ËÐγÉÄòËØ²»½ö¿ÉÒÔ½â³ý°±µÄ¶¾ÐÔ£¬»¹¿ÉÒÔ¼õÉÙÌåÄÚCO2ÈÜÓÚѪҺËù²úÉúµÄËáÐÔ¡£

µÚʮՠºËËá´úл

1.ºËËá´úлÓë°±»ùËá´úлͬÌÇ´úл֮¼äÓÐÄÄЩ¹ØÏµ£¿ ½âÌâÒªµã£º

ºËËá´úлÓë°±»ùËá´úлͬÌÇ´úл֮¼äµÄ¹ØÏµ¼ûÏÂͼ£º

ºËËá ¶àÌÇ HMP ºËÜÕËá ÆÏÌÑÌÇ Á×ËáºËÌÇ EMP Éúͪ°±»ùËá Á×Ëá¶þôDZûͪ Ë¿°±Ëá ÒÒõ£CoA ±ûͪËá ¸Ê°±Ëá

²Ýõ£ÒÒËá ÉúÌǰ±»ùËá TCA»· ±û°±Ëá ¦Á-ͪÎì¶þËá

¹È°±Ëá ¹È°±õ£°· Ì춬°±Ëá Ì춬õ£°·

°±»ùËá

µ°°×ÖÊ

29

ÉúÎﻯѧÃû´Ê½âÊÍ

1£¬Ö¬·¾Ëᣨfatty acid£©£ºÊÇÖ¸Ò»¶Ëº¬ÓÐÒ»¸öôÈ»ùµÄ³¤µÄÖ¬·¾×å̼ÇâÁ´¡£Ö¬·¾ËáÊÇ×î¼òµ¥µÄÒ»ÖÖÖ¬£¬ËüÊÇÐí¶à¸ü¸´ÔÓµÄÖ¬µÄ³É·Ö¡£

2£¬±¥ºÍÖ¬·¾Ëᣨsaturated fatty acid£©£º²»º¬ÓÐ-C=C-Ë«¼üµÄÖ¬·¾Ëá¡£

3£¬²»±¥ºÍÖ¬·¾Ëᣨunsaturated fatty acid£©£ºÖÁÉÙº¬ÓÐ-C=C-Ë«¼üµÄÖ¬·¾Ëá¡£

4£¬±ØÐèÖ¬·¾Ëᣨoccential fatty acid£©£ºÎ¬³Ö²¸È鶯ÎïÕý³£Éú³¤Ëù±ØÐèµÄ£¬¶ø¶¯ÎïÓÖ²»ÄܺϳɵÄÖ¬·¾ËᣬEgÑÇÓÍËᣬÑÇÂéËá¡£

5£¬ÈýÖ¬õ£ÜÕÓÍ£¨triacylglycerol£©£ºÄdzÆÎª¸ÊÓÍÈýõ¥¡£Ò»ÖÖº¬ÓÐÓë¸ÊÓÍÖ¬»¯µÄÈý¸öÖ¬õ£»ùµÄõ¥¡£Ö¬·¾ºÍÓÍÊÇÈýÖ¬õ£¸ÊÓ͵ĻìºÏÎï¡£

6£¬Á×Ö¬£¨phospholipid£©£ºº¬ÓÐÁ×Ëá³É·ÖµÄÖ¬¡£EgÂÑÁ×Ö¬£¬ÄÔÁ×Ö¬¡£

7£¬ÇÊÖ¬£¨sphingolipid£©£ºÒ»ÀຬÓÐÇʰ±´¼¹Ç¼ÜµÄÁ½ÐÔÖ¬£¬Ò»¶ËÁ¬½Ó×ÅÒ»¸ö³¤Á¬µÄÖ¬·¾ËᣬÁíÒ»¶ËΪһ¸ö¼«ÐԺʹ¼¡£ÇÊÖ¬°üÀ¨ÇÊÁ×Ö¬£¬ÄÔÁ×Ö¬ÒÔ¼°Éñ¾­½ÚÜÕÖ¬£¬Ò»°ã´æÔÚÓÚÖ²ÎïºÍ¶¯Îïϸ°ûĤÄÚ£¬ÓÈÆäÊÇÔÚÖÐÊàÉñ¾­ÏµÍ³µÄ×éÖ¯ÄÚº¬Á¿·á¸»¡£

8£¬ÇÊÁ×Ö¬£¨sphingomyelin£©£ºÒ»ÖÖÓÉÉñ¾­õ£°·µÄC-1ôÇ»ùÉÏÁ¬½ÓÁËÁ×ËáëÀïÇ󵨼»òÁ×ËáÒÒõ£°·£©¹¹³ÉµÄÇÊÖ¬¡£ÇÊÁ×Ö¬´æÔÚÓÚÔÚ¶àÊý²¸È鶯ÎﶯÎïϸ°ûµÄÖÊĤÄÚ£¬ÊÇËèÇʵÄÖ÷Òª³É·Ö¡£

9£¬ÂÑÁ×Ö¬£¨lecithin£©£º¼´Á×Ö¬õ£µ¨¼î£¨PC£©£¬ÊÇÁ×Ö¬õ£Ó뵨¼îÐγɵĸ´ºÏÎï¡£

10£¬ÄÔÁ×Ö¬£¨cephalin£©£º¼´Á×Ö¬õ£ÒÒ´¼°·£¨PE£©£¬ÊÇÁ×Ö¬õ£ÓëÒÒ´¼°·Ðγɵĸ´ºÏÎï¡£

11£¬Ö¬ÖÊÌ壨liposome£©£ºÊÇÓɰüΧˮÏà¿Õ¼äµÄÁ×֬˫²ãÐγɵÄÄÒÅÝ£¨Ð¡ÅÝ£©¡£

12£¬ÉúÎïĤ£¨bioligical

membrane£©£ºÏâǶÓе°°×ÖʵÄ֬˫²ã£¬Æð×Å»­·ÖºÍ·Ö¸ôϸ°ûºÍϸ°ûÆ÷×÷ÓÃÉúÎïĤҲÊÇÓëÐí¶àÄÜÁ¿×ª»¯ºÍϸ°ûÄÚͨѶÓйصÄÖØÒª²¿Î»¡£

30

13£¬ÄÚÔÚĤµ°°×£¨integral membrane protein£©£º²åÈë֬˫²ãµÄÊèË®ºËºÍÍêÈ«¿çԽ֬˫²ãµÄĤµ°°×¡£

14£¬ÍâÖÜĤµ°°×£¨peripheral membrane

protein£©£ºÍ¨¹ýÓëĤ֬µÄ¼«ÐÔÍ·²¿»òÄÚÔÚµÄĤµ°°×µÄÀë×ÓÏ໥×÷ÓúÍÐγÉÇâ¼üÓëĤµÄÄÚ»òÍâ±íÃæÈõ½áºÏµÄĤµ°°×¡£ 15£¬Á÷ÌåÏâǶģÐÍ£¨fluid mosaic

model£©£ºÕë¶ÔÉúÎïĤµÄ½á¹¹Ìá³öµÄÒ»ÖÖÄ£ÐÍ¡£ÔÚÕâ¸öÄ£ÐÍÖУ¬ÉúÎïĤ±»ÃèÊö³ÉÏâǶÓе°°×ÖʵÄÁ÷Ìå֬˫²ã£¬Ö¬Ë«²ãÔڽṹºÍ¹¦ÄÜÉ϶¼±íÏÖ³ö²»¶Ô³ÆÐÔ¡£Óеĵ°°×ÖÊ¡°Ïâ¡°ÔÚ֬˫²ã±íÃæ£¬ÓеÄÔò²¿·Ö»òÈ«²¿Ç¶ÈëÆäÄÚ²¿£¬ÓеÄÔòºá¿çÕû¸öĤ¡£ÁíÍâÖ¬ºÍĤµ°°×¿ÉÒÔ½øÐкáÏòÀ©É¢¡£ 16£¬Í¨Í¸ÏµÊý£¨permeability

coefficient£©£ºÊÇÀë×Ó»òС·Ö×ÓÀ©É¢¹ý֬˫²ãĤÄÜÁ¦µÄÒ»ÖÖÁ¿¶È¡£Í¨Í¸ÏµÊý´óСÓëÕâЩÀë×Ó»ò·Ö×ÓÔڷǼ«ÐÔÈÜÒºÖеÄÈܽâ¶È³É±ÈÀý¡£

17£¬Í¨µÀµ°°×£¨channel protein£©£ºÊÇ´øÓÐÖÐÑëË®ÏàͨµÀµÄÄÚÔÚĤµ°°×£¬Ëü¿ÉÒÔʹ´óСÊʺϵÄÀë×Ó»ò·Ö×Ó´ÓĤµÄÈÎÒ»·½Ïò´©¹ýĤ¡£

18£¬£¨Ä¤£©¿×µ°°×£¨pore protein£©£ºÆäº¬ÒâÓëĤͨµÀµ°°×ÀàËÆ£¬Ö»ÊǸÃÊõÓï³£ÓÃÓÚϸ¾ú¡£

19£¬±»¶¯×ªÔË£¨passive

transport£©£ºÄdzÆÎªÒ×»¯À©É¢¡£ÊÇÒ»ÖÖתÔË·½Ê½£¬Í¨¹ý¸Ã·½Ê½ÈÜÖÊÌØÒìµÄ½áºÏÓÚÒ»¸öתÔ˵°°×ÉÏ£¬È»ºó±»×ªÔ˹ýĤ£¬µ«×ªÔËÊÇÑØ×ÅŨ¶ÈÌݶÈϽµ·½Ïò½øÐеģ¬ËùÒÔ±»¶¯×ª´ï²»ÐèÒªÄÜÁ¿µÄÖ§³Ö¡£ 20£¬Ö÷¶¯×ªÔË£¨active

transport£©£ºÒ»ÖÖתÔË·½Ê½£¬Í¨¹ý¸Ã·½Ê½ÈÜÖÊÌØÒìµÄ½áºÏÓÚÒ»¸öתÔ˵°°×ÉÏÈ»ºó±»×ªÔ˹ýĤ£¬Óë±»¶¯×ªÔËÔËÊ䷽ʽÏà·´£¬Ö÷¶¯×ªÔËÊÇÄæ×ÅŨ¶ÈÌݶÈϽµ·½Ïò½øÐеģ¬ËùÒÔÖ÷¶¯×ªÔËÐèÒªÄÜÁ¿µÄÇý¶¯¡£ÔÚÔ­·¢Ö÷¶¯×ªÔ˹ý³ÌÖÐÄÜÔ´¿ÉÒÔÊǹ⣬ATP»òµç×Ó´«µÝ£»¶øµÚ¶þ¼¶Ö÷¶¯×ªÔËÊÇÔÚÀë×ÓŨ¶ÈÌݶÈϽøÐеġ£ 21£¬Ð­Í¬ÔËÊ䣨contransport£©£ºÁ½ÖÖ²»Í¬ÈÜÖʵĿçĤµÄñîÁª×ªÔË¡£¿ÉÒÔͨ¹ýÒ»¸öתÔ˵°°×½øÐÐͬһ·½Ïò£¨Í¬ÏòתÔË£©»ò·´·½Ïò£¨·´ÏòתÔË£©×ªÔË¡£ 22£¬°ûÍÌ£¨ÐÅÓã©£¨endocytosis£©£ºÎïÖʱ»ÖÊĤÍÌÈë²¢ÒÔĤÑÜÉú³ö

31

µÄÖ¬ÄÒÅÝÐγɣ¨ÎïÖÊÔÚÄÒÅÝÄÚ£©±»´øÈ뵽ϸ°ûÄڵĹý³Ì¡£ µÚÆßÕÂ

1£¬ºËÜÕ£¨nucleoside£©£ºÊÇàÑßÊ»òà×़îͨ¹ý¹²¼Û¼üÓëÎìÌÇÁ¬½Ó×é³ÉµÄ»¯ºÏÎï¡£ºËÌÇÓë¼î»ùÒ»°ã¶¼ÊÇÓÉÌǵÄÒìͷ̼Óëà×वÄN-1»òàÑßʵÄN-9Ö®¼äÐγɵĦÂ-N-ÌǼüÁ¬½Ó¡£

2£¬ºËÜÕËᣨuncleoside£©£ººËÜÕµÄÎìÌdzɷÖÖеÄôÇ»ùÁ×ËữÐγɵϝºÏÎï¡£

3£¬cAMP(cycle

AMP)£º3¨@,5¨@-»·ÏÙÜÕËᣬÊÇϸ°ûÄڵĵڶþÐÅʹ£¬ÓÉÓÚij²¿Ð©¼¤ËØ»òÆäËü·Ö×ÓÐźŴ̼¤¼¤»îÏÙÜÕËá»·»¯Ã¸´ß»¯ATP»·»¯Ðγɵġ£ 4£¬Á×Ëá¶þÖ¬¼ü£¨phosphodiester

linkage£©:Ò»ÖÖ»¯Ñ§»ùÍÅ£¬Ö¸Ò»·Ö×ÓÁ×ËáÓëÁ½¸ö´¼£¨ôÇ»ù£©õ¥»¯ÐγɵÄÁ½¸öõ¥¼ü¡£¸Ãõ¥¼ü³ÉÁËÁ½¸ö´¼Ö®¼äµÄÇÅÁº¡£ÀýÈçÒ»¸öºËÜÕµÄ3¨@ôÇ»ùÓë±ðÒ»¸öºËÜÕµÄ5¨@ôÇ»ùÓëͬһ·Ö×ÓÁ×Ëáõ¥»¯£¬¾ÍÐγÉÁËÒ»¸öÁ×Ëá¶þÖ¬¼ü¡£

5£¬ÍÑÑõºËÌǺËËᣨDNA£©£ºº¬ÓÐÌØÊâÍÑÑõºËÌǺËÜÕËáÐòÁеľÛÍÑÑõºËÜÕËᣬÍÑÑõºËÜÕËáÖ®¼äÊÇÊÇͨ¹ý3¨@,5¨@-Á×Ëá¶þÖ¬¼üÁ¬½ÓµÄ¡£DNAÊÇÒÅ´«ÐÅÏ¢µÄÔØÌå¡£

6£¬ºËÌǺËËᣨRNA£©£ºÍ¨¹ý3¨@,5¨@-Á×Ëá¶þÖ¬¼üÁ¬½ÓÐγɵÄÌØÊâºËÌǺËÜÕËáÐòÁеľۺËÌǺËÜÕËá¡£

7£¬ºËÌÇÌåºËÌǺËËᣨRrna,ribonucleic acid£©£º×÷Ϊ×é³É³É·ÖµÄÒ»Àà RNA£¬rRNAÊÇϸ°ûÄÚ×î ·á¸»µÄ RNA .

8£¬ÐÅʹºËÌǺËËá(mRNA,messenger ribonucleic acid):Ò»ÀàÓÃ×÷µ°°×ÖʺϳÉÄ£°åµÄRNA .

9, ×ªÒÆºËÌǺËËᣨTrna,transfer ribonucleic

acid£©:Ò»ÀàЯ´ø¼¤»î°±»ùËᣬ½«Ëü´øµ½µ°°×Öʺϳɲ¿Î»²¢½«°±»ùËáÕûºÏµ½Éú³¤×ŵÄëÄÁ´ÉÏRNA¡£TRNAº¬ÓÐÄÜʶ±ðÄ£°åmRNAÉÏ»¥²¹ÃÜÂëµÄ·´ÃÜÂë¡£ 10£¬×ª»¯£¨×÷Óã©£¨transformation£©:Ò»¸öÍâÔ´DNA ͨ¹ýijÖÖ;¾¶µ¼ÈëÒ»¸öËÞÖ÷¾ú£¬ÒýÆð¸Ã¾úµÄÒÅ´«ÌØÐԸıäµÄ×÷Óá£

11£¬×ªµ¼£¨×÷Óã©£¨transduction£©:½èÖúÓÚ²¡¶¾ÔØÌ壬ÒÅ´«ÐÅÏ¢´Ó

32